Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies

Completed

Conditions studied: Aneuploidy, Down Syndrome, Noninvasive Prenatal Screening

In brief

Pregnant women with low risk indicators for fetal chromosomal aneuploidy will be enrolled. Study blood will be collected in the first or second trimester at a scheduled prenatal screening visit, processed to plasma, and stored frozen until analysis. Each pregnancy will be followed until delivery and the birth outcome recorded.

Key facts

Study ID
NCT01597063
Run by
Sequenom, Inc.
People needed
3333
Starts
2012-07-01
Expected to finish
2015-12-01
Last updated by the study team
2016-04-20

Who can join

Age: 18 and older, up to 34. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.